Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Accumulated Expenses (2022 - 2023)

Historic Accumulated Expenses for 60 Degrees Pharmaceuticals (SXTP) over the last 2 years, with Q4 2023 value amounting to $75000.0.

  • 60 Degrees Pharmaceuticals' Accumulated Expenses fell 7692.31% to $75000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $75000.0, marking a year-over-year decrease of 7692.31%. This contributed to the annual value of $75000.0 for FY2023, which is 7692.31% down from last year.
  • Latest data reveals that 60 Degrees Pharmaceuticals reported Accumulated Expenses of $75000.0 as of Q4 2023, which was down 7692.31% from $295000.0 recorded in Q2 2023.
  • In the past 5 years, 60 Degrees Pharmaceuticals' Accumulated Expenses registered a high of $325000.0 during Q4 2022, and its lowest value of $75000.0 during Q1 2023.